netFormulary
 Report : A-Z HCD items in Formulary 16/07/2018 05:22:22
[Back]
 
Section Status HCD Name
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia®
01.05.03 Formulary Cancer Drugs Fund Adalimumab 
10.01.03 Formulary Cancer Drugs Fund Adalimumab 
13.05.03 Formulary Cancer Drugs Fund Adalimumab 
09.01 Non Formulary Cancer Drugs Fund Afamelanotide Scenesse®
11.08.02 Formulary Cancer Drugs Fund Aflibercept 
02.12 Formulary Cancer Drugs Fund Alirocumab 
13.05.01 Formulary Cancer Drugs Fund Alitretinoin 
10.01.03 Non Formulary Cancer Drugs Fund Anakinra Kineret®
13.05.03 Formulary Cancer Drugs Fund Apremilast 
10.01.03 Formulary Cancer Drugs Fund Baricitinib 
11.08.02 Formulary Cancer Drugs Fund Bevacizumab intravitreal injection 
04.07.04.02 Formulary Cancer Drugs Fund Botulinum toxin A Botox®
04.09.03 Non Formulary Cancer Drugs Fund Botulinum toxin A Azzalure®, Bocouture®,Botox®,Vistabel®
04.09.03 Formulary Cancer Drugs Fund Botulinum toxin A Azzalure®, Bocouture®, Botox®, Vistabel®, Dysport®, Xeomin®
07.04.02 Formulary Cancer Drugs Fund Botulinum toxin A  Botox®
13.12 Non Formulary Cancer Drugs Fund Botulinum toxin A  Botox®
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol 
10.03.01 Non Formulary Cancer Drugs Fund Collagenase 
11.04.01 Formulary Cancer Drugs Fund Dexamethasone intravitreal implant Ozurdex®
06.06.02 Non Formulary Cancer Drugs Fund Dibotermin Alfa 
02.01.01 Formulary Cancer Drugs Fund Digoxin specific antibody fragments DigiFab®
13.05.02 Formulary Cancer Drugs Fund Dimethyl Fumarate Skilarence ®
09.01.04 Formulary Cancer Drugs Fund Eltrombopag 
06.06.02 Non Formulary Cancer Drugs Fund Eptotermin Alfa  
10.01.03 Formulary Cancer Drugs Fund Etanercept 
13.05.03 Formulary Cancer Drugs Fund Etanercept 
02.12 Formulary Cancer Drugs Fund Evolocumab 
09.02.02.02 Non Formulary Cancer Drugs Fund Fibrin sealants 
11.04.01 Formulary Cancer Drugs Fund Fluocinolone intravitreal implant Iluvien®
13.05.02 Non Formulary Cancer Drugs Fund Fumaric acid esters  Fumaderm®
01.05.03 Formulary Cancer Drugs Fund Golimumab 
10.01.03 Formulary Cancer Drugs Fund Golimumab 
01.05.03 Formulary Cancer Drugs Fund Infliximab 
10.01.03 Formulary Cancer Drugs Fund Infliximab 
13.05.03 Formulary Cancer Drugs Fund Infliximab 
13.05.03 Formulary Cancer Drugs Fund Ixekizumab 
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide 
11.08.02 Formulary Cancer Drugs Fund Ocriplasmin intravitreal injection 
08.03.04.03 Formulary Cancer Drugs Fund Octreotide 
03.04.02 Formulary Cancer Drugs Fund Omalizumab 
11.08.02 Non Formulary Cancer Drugs Fund Pegaptanib 
11.08.02 Formulary Cancer Drugs Fund Ranibizumab intravitreal injection 
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek®
09.01.04 Formulary Cancer Drugs Fund Rituximab 
10.01.03 Formulary Cancer Drugs Fund Rituximab  
09.01.04 Formulary Cancer Drugs Fund Romiplostim 
10.01.03 Formulary Cancer Drugs Fund Sarilumab 
13.05.03 Formulary Cancer Drugs Fund Secukinumab 
04.01.01 Non Formulary Cancer Drugs Fund Sodium Oxybate 
06.05.01 Formulary Cancer Drugs Fund Somatropin 
07.04.01 Non Formulary Cancer Drugs Fund Tadalafil 5 mg Cialis®
04.09.03 Non Formulary Cancer Drugs Fund Tafamidis 
01.04.02 Non Formulary Cancer Drugs Fund TeduglutideRestricted Item Revestive®
06.06.01 Formulary Cancer Drugs Fund Teriparatide 
06.05.01 Non Formulary Cancer Drugs Fund Tesamorelin 
10.01.03 Formulary Cancer Drugs Fund Tocilizumab oral & sc injection 
10.01 Formulary Cancer Drugs Fund Tofacitinib 
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Jinarc®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab 
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
01.05.03 Formulary Cancer Drugs Fund Vedolizumab 
11.08.02 Formulary Cancer Drugs Fund Verteporfin 
Coventry and Warwickshire Area Prescribing Committee